MedPath

Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis

Phase 4
Conditions
Renal Failure, End Stage
Peritoneal Dialysis
Registration Number
NCT00291863
Lead Sponsor
Federal University of São Paulo
Brief Summary

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Detailed Description

This study will analyse the effect of simvastatin on endothelium dependent venodilation in chronic renal failure patients treated by peritoneal dialysis. The hypothesis is that patients will have a greater endothelium dependent venodilation after four months of simvastatin use.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • end stage renal failure
  • peritoneal dialysis
  • LDL cholesterol > 100mg/dL
  • > 18 years and < 80 years
Exclusion Criteria
  • using statin or nitrate
  • liver disease
  • diabetes mellitus

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
endothelial venodilation
Secondary Outcome Measures
NameTimeMethod
Inflammation markers (C-reactive protein, IL-6, TNF)
Lipoproteins
Oxidative stress

Trial Locations

Locations (1)

São Lucas Hospital

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath